Ariad Pharmaceuticals Inc (NASDAQ:ARIA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

1
Player Avatar JesusForgives (52.40) Submitted: 4/1/2010 5:31:14 AM : Outperform Start Price: $3.41 ARIA Score: +13.75

This stock could just be a good pick to do a cover call option for may10 if my figures are right you could see a return of 14% for the month.

Featured Broker Partners


Advertisement